Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer (Q33774648)

29 July 2017

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer (English)

1 reference

29 July 2017

0 references

1 reference

Shelley M Herbrich

3

0 references

Anna K. Unruh

Anna K Unruh

4

0 references

Kshipra Gharpure

Kshipra Gharpure

2

0 references

Rajesha Rupaimoole

Rajesha Rupaimoole

11

0 references

Cristina Ivan

Cristina Ivan

14

0 references

Anil K. Sood

17

Anil K Sood

1 reference

29 July 2017

Susan L Tucker

1

1 reference

29 July 2017

Alpa M Nick

5

1 reference

29 July 2017

Erin K Crane

6

1 reference

29 July 2017

Robert L Coleman

7

1 reference

29 July 2017

Jamie Guenthoer

8

1 reference

29 July 2017

Heather J Dalton

9

1 reference

29 July 2017

Sherry Y Wu

10

1 reference

29 July 2017

Gabriel Lopez-Berestein

12

1 reference

29 July 2017

Bulent Ozpolat

13

1 reference

29 July 2017

Wei Hu

15

1 reference

29 July 2017

Keith A Baggerly

16

1 reference

29 July 2017

language of work or name

English

0 references

publication date

22 April 2014

1 reference

29 July 2017

Clinical Cancer Research

1 reference

29 July 2017

20

1 reference

29 July 2017

12

1 reference

29 July 2017

3280-3288

1 reference

Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

RNA interference-based silencing reveals the regulatory role of fatty acid-binding protein 4 in the production of IL-6 and vascular endothelial growth factor in 3T3-L1 adipocytes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Rethinking ovarian cancer: recommendations for improving outcomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Integrated genomic analyses of ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Tackling the widespread and critical impact of batch effects in high-throughput data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

28 July 2018

12 December 2020

Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

A gene expression bar code for microarray data

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062703

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

30 October 2018

1 reference

12 December 2020

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

1 reference

12 December 2020

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

12 December 2020

Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer

1 reference

12 December 2020

10.1158/1078-0432.CCR-14-0445

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference